Your browser doesn't support javascript.
loading
Review on Pricing Policy of Patent Drugs in UK / 中国药房
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-531913
ABSTRACT

OBJECTIVE:

To evaluate the pricing policy on the patent drugs in UK.

METHODS:

The current pricing policy on patent drugs in UK and the outcome of the policy were analyzed and its characteristics and applicable condition were summarized.RESULTS &

CONCLUSIONS:

Current pricing policy on patent drugs in UK provided incentives for the research & development as well as innovation of drugs and it helped to keep UK's pharmaceutical industries in the global leading level.However,there is no mechanism within it to take explicit account of therapeutic value of drugs.Also,it provides weak incentives to invest in the most cost-effective yet clinically demanded drugs and it has limited effect on price control of drugs.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article